RIM1 α forms a protein scaffold for regulating neurotransmitter release at the 
active zone

Schoch, Susanne; Castillo, Pablo E.; Jo, Tobias; Mukherjee, Konark; Geppert, Martin; Wang, Yun; Schmitz, Frank; Malenka, Robert C.; Südhof, Thomas C.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

RIM1 α forms a protein scaffold for regulating neurotransmitter release at the active zone

MPS-Authors

Geppert, Martin
Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schoch, S., Castillo, P. E., Jo, T., Mukherjee, K., Geppert, M., Wang, Y., et al. (2002). RIM1 α forms a protein scaffold for regulating neurotransmitter release at the active zone. Nature, 415(6869), 321-326.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0029-0BDE-6

Abstract

Neurotransmitters are released by synaptic vesicle fusion at the active zone(1,2). The active zone of a synapse mediates Ca2+-triggered neurotransmitter release, and integrates presynaptic signals in regulating this release. Much is known about the structure of active zones and synaptic vesicles, but the functional relation between their components is poorly understood(3). Here we show that RIM1alpha, an active zone protein that was identified as a putative effector for the synaptic vesicle protein Rab3A(4,5), interacts with several active zone molecules, including Munc13-1 (ref. 6) and alpha- liprins(7,8), to form a protein scaffold in the presynaptic nerve terminal. Abolishing the expression of RIM1alpha in mice shows that RIM1alpha is essential for maintaining normal probability of neurotransmitter release, and for regulating release during short-term synaptic plasticity. These data indicate that RIM1alpha has a central function in integrating active zone proteins and synaptic vesicles into a molecular scaffold that controls neurotransmitter release.